New Insights into Cellular Transplantation and Immunotherapy
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".
Deadline for manuscript submissions: closed (15 June 2022) | Viewed by 11856
Special Issue Editor
Interests: hematopoietic stem cells; stem cell biology; stem cell transplantation; aging; leukemia stem cells; hematopoietic neoplasms
Special Issue Information
Dear Colleagues,
Cellular transplantation has long been used in various medical fields to replace diseased or abnormal cells and to regenerate heathy organs. In addition to traditional transplantation, recent biotechnological advances have enabled us to engineer artificially designed cells from our own (e.g., chimeric antigen receptor T cells) and to use them in clinical practice, such as immunotherapy. The notion of such “designer cells” has been attracting broad attention in the cellular transplantation field because it paves the way for a prosperous future for customized medicine to cure not only cancers but also intractable genetic diseases.
This Special Issue invites manuscripts providing new insights into cellular transplantation and immunotherapy. We are interested in a wide range of work from different medical sections, including cardiovascular biology, gastroenterology, hepatology, endocrinology, immunology, hematology, and neuroscience. Review or original articles on stem cell biology, cell culture systems, and tissue engineering for transplantation are also important. Finally, comprehensive papers regarding ethics, safety, and technology relevant to the new era of cellular transplantation are also welcome.
Dr. Takafumi Yokota
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- transplantation
- stem cells
- designer cells
- tissue engineering
- cell therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.